Bryan Mazlish

Bryan Mazlish has a strong background in the biotech and finance industries. Bryan is currently the Founder and Chief Executive Officer of Surf Bio, a company that focuses on improving drug delivery for various therapeutics. Prior to this, Mazlish founded and held multiple roles at Bigfoot Biomedical, where they aimed to revolutionize care for insulin-requiring diabetes patients through technology. Bryan also has experience as an Angel Investor in various startups. Before their involvement in the healthcare industry, Mazlish founded and managed Overlook Capital, a proprietary trading firm specializing in algorithmic trading. Bryan began their career at Citi (formerly Salomon Brothers), where they rose to a senior leadership position within the Equities trading division and played a key role in introducing new products and generating significant revenues. Overall, Mazlish brings a diverse range of experiences spanning multiple industries to their work in biotech and finance.

Bryan Mazlish attended Harvard University from 1990 to 1994, where they earned a Bachelor of Arts (B.A.) degree in Computer Science.